NCT05559762

Brief Summary

This study will determine whether nurses regularly working night shifts have elevated 24-hour glucose levels compared to nurses regularly working day shifts, using continuous glucose monitoring (CGM).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

November 8, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
Last Updated

March 10, 2025

Status Verified

March 1, 2025

Enrollment Period

9 months

First QC Date

September 26, 2022

Last Update Submit

March 6, 2025

Conditions

Circadian Rhythm; InversionMetabolic Disease

Outcome Measures

Primary Outcomes (1)

  • 24hr glucose

    continuous glucose monitoring

    7 days

Study Arms (2)

Day Shift

Nurses regularly working 12hr day shifts

Night Shift

Nurses regularly working night shift

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Full time nurses working either day shifts or night shifts

You may qualify if:

  • RNs working at least a 0.6 FTE and 12-hour night or day shift (not able to alternate between days and nights) for at least the past two months
  • Free from presence of uncontrolled chronic illness and specifically prediabetes, Type 1 or Type 2 diabetes (but not including history of gestational diabetes) and not currently taking any glucose-lowering or steroid medication
  • Not currently pregnant or breastfeeding
  • English speaking and able to provide informed consent
  • Must own and know how to operate a Smartphone
  • Must be willing and able to wear two small sensors attached by adhesive for the study duration, the Fibion SENS activity monitor and the Dexcom G6 continuous glucose monitor
  • Must regularly consume food during shifts and refrain from actively attempting weight loss during the study duration
  • Must work only one job at the time of study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Providence Sacred Heart Hospital

Spokane, Washington, 99204, United States

Location

MeSH Terms

Conditions

Metabolic Diseases

Condition Hierarchy (Ancestors)

Nutritional and Metabolic Diseases

Study Officials

  • Lindsey Miller

    Lincoln Memorial University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 26, 2022

First Posted

September 29, 2022

Study Start

November 8, 2022

Primary Completion

July 30, 2023

Study Completion

July 30, 2023

Last Updated

March 10, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations

US(1)